Impact of appropriate use criteria for transesophageal echocardiograms on clinically meaningful care.


Journal

Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 07 2018
revised: 09 10 2018
accepted: 09 10 2018
pubmed: 20 11 2018
medline: 6 5 2019
entrez: 20 11 2018
Statut: ppublish

Résumé

The aim of this study was to evaluate appropriateness of transesophageal echocardiography (TEE) studies based on 2011 Appropriate Use Criteria (AUC) for Echocardiography and its impact on patient management. In a retrospective analysis of 100 inpatient TEEs, 85% of the TEEs ordered were determined to be appropriate, 9% were inappropriate, and 6% were uncertain. Inter-observer differences in the determination of AUC were seen in 24% of the studies, requiring a senior-level cardiologist to make the final determination of AUC score. The variance in interpretation by experts is concerning for how that might translate into differences in clinical practice. Of all TEEs, only 63% led to an active change in care, including changes in medications or procedures, while 37% did not. We found a statistically significant difference between cardiologists' and non-cardiologists' orders for TEE having an impact on patient's clinical care (41% vs 22%, respectively, P < 0.05) (Table ). While not statistically significant, a trend toward clinical change was observed in the appropriate vs inappropriate TEEs (70% vs 44%, respectively, P = 0.06). Ideally, the role of a diagnostic cardiovascular imaging test, such as a TEE, is to influence clinical care, if it is ordered appropriately on the right patient. While the AUC guides clinicians on the appropriate use of cardiovascular imaging, it is broadly written and offers room for interpretation to encompass variety of clinical scenarios. Clinical care paths that utilize AUC and standardize use of multidisciplinary institutional resources offer opportunity for optimal clinical impact and patient care.

Identifiants

pubmed: 30450684
doi: 10.1111/echo.14189
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-21

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Tripti Gupta (T)

Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.

Eiman Jahangir (E)

Department of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Yvonne Gilliland (Y)

Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.

Carl J Lavie (CJ)

Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Ochsner Clinical School, University of Queensland School of Medicine, Brisbane, Queensland, Australia.

Sangeeta Shah (S)

Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Ochsner Clinical School, University of Queensland School of Medicine, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH